Medical Disposables Market

Global Medical Disposables Market Size (2024 to 2032)

The global medical disposables market was valued at USD 306.8 billion in 2023. The size of the global medical disposables is estimated to be worth USD 359.3 billion in 2024 and USD 1279.02 billion by 2032, growing at a CAGR of 17.20% during the forecast period.

A disposable device is any medical device intended to be used only once or briefly. Many different types of disposable devices are manufactured by medical and surgical device manufacturers around the world. The primary reason for developing disposable devices is to prevent infection. When an item is only used once, infectious agents cannot be passed on to subsequent patients. Disposable and reusable medical textiles with designed barrier properties against infectious diseases are now widely used in hospitals. While COVID-19 remains a threat in healthcare worldwide, surgeons will undoubtedly adapt to non-surgical roles in the critical fight against the COVID-19 pandemic. The healthcare industry constantly evolves, from policy to patients and everything in between. The future of disposable medical devices is difficult to predict because the market is driven by new technology, while market demands drive technological advances.

MARKET DRIVERS

The growing number of surgeries worldwide is majorly driving the global medical disposables market growth.

Surgery is now carried out on a large scale worldwide, in wealthy and impoverished settings, which is abhorrent. In general, minimally invasive surgery is associated with less pain, shorter hospital stays, and fewer complications. Laparoscopy was one of the first minimally invasive surgery, which involved performing surgery through one or more small incisions while using surgical equipment. In 2018, at least 1.16 million cesarean sections were performed in the EU-27. In recent years, the use of in-patient procedures for cataract surgery has decreased in nearly all EU Member States.

Rising incidence of Healthcare-Associated Infections (HAIs) to increase the use of disposable medical supplies.

Healthcare-associated infections (HAI) are a common cause of morbidity and mortality, putting significant financial strain on healthcare systems. According to WHO, healthcare-associated infections (HAI) are directly responsible for 37,000 deaths in Europe each year, and they play a role in an additional 110,000 deaths. In the United States, 99,000 deaths are attributable to alcohol each year. Preventable HAI-related ICU deaths may account for a quarter or more of all deaths in low-resource countries. According to the CDC, it is the national authority on HAI surveillance, outbreak investigation, laboratory research, and prevention.

The rising prevalence of chronic diseases such as diabetes and heart disease is further expected to accelerate the global medical disposables market growth.

Chronic diseases kill 41 million people worldwide yearly, accounting for 71% of all deaths. Furthermore, 77 percent of all NCD deaths occur in low- and middle-income countries. The majority of Chronic disease deaths (17.9 million per year) are caused by cardiovascular diseases, followed by respiratory diseases (4.1 million), cancers (9.3 million), and diabetes (1.5 million). The global burden of chronic diseases is rising rapidly. According to WHO, chronic diseases (NCDs) kill 41 million people yearly, accounting for 71% of all deaths worldwide. According to CDC, Diabetes is the seventh most common cause of death in the US. Diabetes affects over 34 million people in the United States. In 2019, diabetes was directly responsible for an estimated 1.5 million deaths. In low- and middle-income countries, prevalence has risen faster than in high-income countries.

Additionally, factors such as the number of patients suffering from infectious diseases rises, so will the demand for disposable medical supplies, the global impact of the COVID-19 outbreak, the growing geriatric population worldwide, increasing production levels of medical disposables by the pharmaceutical and medical device companies, high demand for healthcare services all over the world and increasing spending on healthcare facilities around the world are predicted to favor the growth rate of the global medical disposables market.

MARKET RESTRAINTS

The problem of adverse skin events has grown exponentially due to the prolonged use of personal protective equipment, which is expected to showcase a negative impact on the global medical disposables market. Additionally, strict GMPs are another significant restraint to the global medical disposables market growth. On the other hand, raw material cost variations are a stumbling block for the healthcare packaging industry. Demand for home care services is growing; however, some physicians, patients, and consumers may be unaware of certain medical device information.

REPORT COVERAGE

This research report on the global medical disposables market has been segmented and sub-segmented based on product, raw material, end-user, and region.

Medical Disposables Market Analysis By Product

• Wound Management Products
• Drug Delivery Products
• Diagnostic and Laboratory Disposables
• Dialysis Disposables
• Incontinence Products
• Respiratory Supplies
• Sterilization Supplies
• Non-woven Disposables
• Disposable Masks
• Disposable Eye Gear
• Disposable Gloves
• Hand Sanitizers
  • Gel Sanitizers
  • Foam Sanitizers
  • Liquid Sanitizers
  • Other Sanitizers
• Others

Medical Disposables Market Analysis By Raw Material

• Plastic Resins
• Nonwoven Material
• Rubber
• Paper and Paperboard
• Metals
• Glass
• Others

Medical Disposables Market Analysis By End-User

• Hospitals
• Home Healthcare
• Outpatient/Primary Care Facilities
• Others

Medical Disposables Market Analysis By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• The Middle East and Africa

KEY MARKET PARTICIPANTS

A few of the notable participants dominating the global medical disposables market profiled in this report are Medline Industries, Inc., Kimberley-Clark, Bayer AG, Cardinal Health, Smith & Nephew PLC, 3M Company, Covidien, Medtronic, Johnson & Johnson, Becton, Dickinson & Company and Abbott.